OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 109 filers reported holding OCULAR THERAPEUTIX INC in Q3 2020. The put-call ratio across all filers is 1.19 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $70,635 | -1.9% | 13,689 | -20.8% | 0.00% | – |
Q3 2022 | $72,000 | -51.4% | 17,291 | -53.1% | 0.00% | -100.0% |
Q2 2022 | $148,000 | -25.6% | 36,891 | +85.3% | 0.00% | 0.0% |
Q3 2021 | $199,000 | -59.6% | 19,913 | -42.6% | 0.00% | -50.0% |
Q2 2021 | $492,000 | +49.5% | 34,681 | +73.2% | 0.00% | 0.0% |
Q1 2021 | $329,000 | +53.7% | 20,026 | +94.1% | 0.00% | 0.0% |
Q4 2020 | $214,000 | -75.9% | 10,315 | -91.2% | 0.00% | -83.3% |
Q3 2020 | $889,000 | -28.5% | 116,846 | -21.7% | 0.01% | -40.0% |
Q2 2020 | $1,243,000 | +886.5% | 149,257 | +487.1% | 0.02% | +566.7% |
Q1 2020 | $126,000 | +186.4% | 25,424 | +77.2% | 0.00% | – |
Q3 2019 | $44,000 | -55.6% | 14,348 | -35.5% | 0.00% | -100.0% |
Q4 2017 | $99,000 | -32.2% | 22,243 | +41.6% | 0.00% | -33.3% |
Q2 2017 | $146,000 | -71.4% | 15,703 | -74.3% | 0.00% | -85.7% |
Q4 2016 | $510,000 | – | 60,985 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |